期刊文献+

基因治疗病毒载体何去何从 被引量:1

What Course to Follow Does the Virus Vector in Genetic Therapy
下载PDF
导出
摘要 8 0 %的基因治疗采用转染率较高的病毒载体 ,但应用病毒作为载体有可能在复制过程中增加活性病毒的拷贝 ,诱发宿主细胞免疫反应或癌变等副作用。以病毒为载体因为诸多隐患而逐渐退出基因治疗的历史舞台 ,安全。 Almost eighty percent genetic therapy teats adopted virus as vector. But vector will replicate living virus, induce immunoreaction or neobiogenesis and so on side effects. For the reasons mentioned above the virus-vector will vanish form genetic therapy. Investigating safety and effective non-virus vector is the goal of genetic therapy.
出处 《医学与哲学》 北大核心 2005年第4期70-71,共2页 Medicine and Philosophy
关键词 基因治疗 病毒载体 非病毒载体 genetic therapy virus vector non-virus vector
  • 相关文献

参考文献6

  • 1ANDERSON W F. Human gene therapy[J]. Science, 1992,256:808-813.
  • 2ZOUYY, ZONGG, LINGYH, etal. Development of cationic liposome formulations for intracheal gene therapy of early lung cancer[J].Cancer Gene Ther, 2000,7,683:10 - 17.
  • 3CHAVANYC,SAISON-BEHMOARST, LEDOANT, et al. Adsorption of oligonucleotides onto poly(isohexylcyanoacrylate) nanopartides protects them against nuclease their and increase their celluar uptake[J]. Pharm Res, 1994,11:1370 - 1378.
  • 4GRIMES B R, WARBURTON P E, FARR C J. Chromosome engineering: prospects for gene therapy[J]. Gene Ther, 2002, 9:713-718.
  • 5KUROIWA Y, YOSHIDAH, OHSHIMAT, et al. The useof chroosome - based vectors for animal transgenesis[J]. Gene Ther, 2002,9:708 - 712.
  • 6邹从清.试析基因治疗中的不当与恰当问题[J].医学与哲学,2002,23(9):37-39. 被引量:4

共引文献3

同被引文献18

  • 1章樱,强卫国.原发性高血压基因治疗研究进展[J].中华高血压杂志,2007,15(10):801-803. 被引量:4
  • 2Phillips MI. Somatic gene therapy for hypertension. Braz J Med Biol Res, 2000,33 : 715-721.
  • 3Lin KF, Chan J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Hum Gene Ther, 1998,9:1429-1438.
  • 4Chao J, Zhang JJ, Lin KF, et al. Human kallikrein gene deliv- ery attenuates hypertension, cardiac hypertrophy, and renal in jury in Dahl salt-sensitive rats. Hum Gene Ther, 1998,9:21-31.
  • 5Kimura B, Mohuczy D, Tang X, et al. Attenuation of hyperten- sion and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension, 2001,37 : 376-380.
  • 6Wang H, Lu D, Reaves PY, et al. Retrovirally mediated deliv- ery of angiotensin lI type 1 receptor antisense in vitro and in vivo. Methods Enzymol, 2000,314: 581-590.
  • 7Galli SM, Phillips MI. Angiotensin 1I AT (1A) receptor anti- sense lowers blood pressure in acute 2-kidney, 1-clip hyperten- sion. Hypertension, 2001,38 : 674-678.
  • 8Gelband CH, ang H,Gardon ML, et al. Angiotensin I -convert- ing enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats.Hypertension, 2000,35 : 209-213.
  • 9Wang H, Reaves PY, Gardon ML, et al. Angiotensin I -con- verting enzyme antisense gene therapy causes permanent antihy- pertensive effects in the SHR. Hypertension, 2000,35 : 202-208.
  • 10Zhang YC, Bui JD, Shen L, et al. Antisense inhibition of beta (1)-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats. Circulation, 2000,101 : 682 - 688.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部